参考文章(20)
Bernie J. O'Brien, Economic evaluation of pharmaceuticals McMaster University. ,(1995)
Drummond Rennie, Fair conduct and fair reporting of clinical trials. JAMA. ,vol. 282, pp. 1766- 1768 ,(1999) , 10.1001/JAMA.282.18.1766
Mark Friedberg, Bernard Saffran, Tammy J Stinson, Wendy Nelson, Charles L Bennett, Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology JAMA. ,vol. 282, pp. 1453- 1457 ,(1999) , 10.1001/JAMA.282.15.1453
CYNTHIA D. MULROW, The Medical Review Article: State of the Science Annals of Internal Medicine. ,vol. 106, pp. 485- 488 ,(1987) , 10.7326/0003-4819-106-3-485
Herbert Rakatansky, Sources of bias in the economic analysis of new drugs. JAMA. ,vol. 283, pp. 1423- 1424 ,(2000) , 10.1001/JAMA.283.11.1421
David Moher, Deborah J Cook, Susan Eastwood, Ingram Olkin, Drummond Rennie, Donna F Stroup, Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement The Lancet. ,vol. 354, pp. 1896- 1900 ,(1999) , 10.1016/S0140-6736(99)04149-5
Marcia Angell, Robert D. Utiger, Alastair J.J. Wood, Disclosure of Authors' Conflicts of Interest: A Follow-up New England Journal of Medicine. ,vol. 342, pp. 586- 587 ,(2000) , 10.1056/NEJM200002243420812
Drummond Rennie, When Authorship Fails JAMA. ,vol. 278, pp. 579- 585 ,(1997) , 10.1001/JAMA.1997.03550070071041
Kevin Schulman, Daniel P Sulmasy, Deborah Roney, Ethics, Economics, and the Publication Policies of Major Medical Journals JAMA: The Journal of the American Medical Association. ,vol. 272, pp. 154- 156 ,(1994) , 10.1001/JAMA.1994.03520020080023